These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19221203)

  • 1. Estrogen and mechanisms of vascular protection.
    Xing D; Nozell S; Chen YF; Hage F; Oparil S
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):289-95. PubMed ID: 19221203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian hormones and vascular disease.
    Hage FG; Oparil S
    Curr Opin Cardiol; 2013 Jul; 28(4):411-6. PubMed ID: 23736815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging women and their endothelium: probing the relative role of estrogen on vasodilator function.
    Somani YB; Pawelczyk JA; De Souza MJ; Kris-Etherton PM; Proctor DN
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H395-H404. PubMed ID: 31173499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and the cardiovascular system.
    Knowlton AA; Lee AR
    Pharmacol Ther; 2012 Jul; 135(1):54-70. PubMed ID: 22484805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-TNF interactions and vascular inflammation.
    Ferreri NR
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2566-9. PubMed ID: 17351072
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of estrogen and estrogen-related drugs in cardiovascular diseases.
    Ogita H; Node K; Kitakaze M
    Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ageing, oestrogen, platelets and thrombotic risk.
    Miller VM; Jayachandran M; Owen WG
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):814-21. PubMed ID: 17600564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and endothelial dysfunction during aging: role of NF-kappaB.
    Csiszar A; Wang M; Lakatta EG; Ungvari Z
    J Appl Physiol (1985); 2008 Oct; 105(4):1333-41. PubMed ID: 18599677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor ligands in the control of pathogenic inflammation.
    Harnish DC
    Curr Opin Investig Drugs; 2006 Nov; 7(11):997-1001. PubMed ID: 17117588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here?
    Dubey RK; Imthurn B; Zacharia LC; Jackson EK
    Hypertension; 2004 Dec; 44(6):789-95. PubMed ID: 15477384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolism on the safety of estrogen therapy.
    Prokai-Tatrai K; Prokai L
    Ann N Y Acad Sci; 2005 Jun; 1052():243-57. PubMed ID: 16024767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen in vascular smooth muscle cells: A friend or a foe?
    Dehaini H; Fardoun M; Abou-Saleh H; El-Yazbi A; Eid AA; Eid AH
    Vascul Pharmacol; 2018 Dec; 111():15-21. PubMed ID: 30227233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging.
    Simoncini T
    Climacteric; 2009; 12 Suppl 1():6-11. PubMed ID: 19811233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and stroke.
    Billeci AM; Paciaroni M; Caso V; Agnelli G
    Curr Vasc Pharmacol; 2008 Apr; 6(2):112-23. PubMed ID: 18393913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
    Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and Cardiovascular Disease: Is Timing Everything?
    Giordano S; Hage FG; Xing D; Chen YF; Allon S; Chen C; Oparil S
    Am J Med Sci; 2015 Jul; 350(1):27-35. PubMed ID: 26110752
    [No Abstract]   [Full Text] [Related]  

  • 20. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.